Actelion (Actelion) Beginning Cash Position : $495 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Beginning Cash Position?

Actelion's Beginning Cash Position for the quarter that ended in Mar. 2017 was $495 Mil.

Actelion's quarterly Beginning Cash Position declined from Sep. 2016 ($430 Mil) to Dec. 2016 ($403 Mil) but then increased from Dec. 2016 ($403 Mil) to Mar. 2017 ($495 Mil).

Actelion's annual Beginning Cash Position increased from Dec. 2014 ($644 Mil) to Dec. 2015 ($1,211 Mil) but then declined from Dec. 2015 ($1,211 Mil) to Dec. 2016 ($397 Mil).

Actelion Beginning Cash Position Historical Data

The historical data trend for Actelion's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Beginning Cash Position Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Beginning Cash Position

Get a 7-Day Free Trial

1,390.47

1,144.38

643.54

1,210.89

397.19

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Beginning Cash Position	Get a 7-Day Free Trial															412.69	486.44	429.93	402.89	494.64

Actelion Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Actelion Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Actelion's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017